Stock listing
A2P7XN Stock Price, News, Filings & Events — Betterlife Pharma Inc.
Selected listing: A2P7XN · LS · EUR · DE
This page tracks Betterlife Pharma Inc.'s A2P7XN:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A2P7XN:LS. A2P7XN:LS is the stock-level entry point for investors researching Betterlife Pharma Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- A2P7XN:LS
- Asset type
- Stock
- Market cap
- $35.7M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- LS
- Currency
- EUR
Betterlife Pharma Inc. A2P7XN:LS stock context
This page tracks Betterlife Pharma Inc.'s A2P7XN:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A2P7XN:LS. A2P7XN:LS is the stock-level entry point for investors researching Betterlife Pharma Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Betterlife Pharma Inc.
BetterLife Pharma Inc. Announces Filing of Final Prospectus for US$100 Million Public Offering of Common Shares and Pre-Funded Warrants
September 11, 2026
Better Home & Finance Holding Company (BETR) Shareholders Who Lost Money - Contact Law Offices of Howard G. Smith About Continuing Securi...
September 7, 2026
Better Home & Finance Responds to Former CEO Vishal Garg's Latest Unrealistic and Grandiose "Plan" That Lacks Operational Foundation
September 3, 2026
BetterLife Pharma Appoints Charles Duncan as Director and Chair of the Audit Committee
August 31, 2026
BetterLife Pharma Inc. Announces Pricing of US$100 Million Public Offering of Common Shares and Pre-Funded Warrants
August 28, 2026
Research Betterlife Pharma Inc.
Betterlife Pharma Inc. investor report
Review AI stock analysis and investor report context for A2P7XN:LS.
Betterlife Pharma Inc. company profile
View the public company page for Betterlife Pharma Inc. on 6ix.
Betterlife Pharma Inc. news
Read company news and market updates connected to Betterlife Pharma Inc..
Betterlife Pharma Inc. investor events
Find investor webinars, events, and replay context for Betterlife Pharma Inc..
Alternate listings
BETR:CSE
CA · CAD
Alternate listing for Betterlife Pharma Inc.; the primary context on this page is A2P7XN:LS.
BETRF:OTC
US · USD
Alternate listing for Betterlife Pharma Inc.; the primary context on this page is A2P7XN:LS.
BETR:NEO
CA · CAD
Alternate listing for Betterlife Pharma Inc.; the primary context on this page is A2P7XN:LS.
NPAU:FWB
DE · EUR
Alternate listing for Betterlife Pharma Inc.; the primary context on this page is A2P7XN:LS.
A2P7XN:LSX
DE · EUR
Alternate listing for Betterlife Pharma Inc.; the primary context on this page is A2P7XN:LS.
NPAU:GETTEX
DE · EUR
Alternate listing for Betterlife Pharma Inc.; the primary context on this page is A2P7XN:LS.
NPAU:SWB
DE · EUR
Alternate listing for Betterlife Pharma Inc.; the primary context on this page is A2P7XN:LS.
NPAU:MUN
DE · EUR
Alternate listing for Betterlife Pharma Inc.; the primary context on this page is A2P7XN:LS.